A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma
A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma
Recruiting · NCT05797805 · Registry updated 2025-07-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma | Advanced Hepatocellular Carcinoma | Recruiting | Phase 1 / Phase 2 | 2025-07-04 | NCT05797805 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Iterion Therapeutics | 3 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| City of Hope | Duarte | United States | 238 |
| Fred Hutchinson Cancer Center | Seattle | United States | 1 |
| Levine Cancer Institute | Charlotte | United States | 110 |
| MD Anderson Cancer Center | Houston | United States | 589 |
| Sylvester Comprehensive Cancer Center | Miami | United States | 37 |
| UHN - Princess Margaret Cancer Centre | Toronto | Canada | 1 |
| University of Chicago | Chicago | United States | 312 |
| UT Southwestern | Dallas | United States | 33 |